Wellcon Caniheart BZ 2.5/5mg Tablet (Pimobendan & Benazepril) for Dogs
This low-strength variant provides synergistic inodilator therapy pimobendan enhances cardiac contractility and vasodilation while benazepril (ACE inhibitor) reduces preload/afterload—for early-stage or small-breed canine heart disease management.
-
Composition : Pimobendan 2.5mg (positive inotrope/vasodilator).
Benazepril HCl 5mg (angiotensin-converting enzyme inhibitor).
Palatable chewable base with beef/liver flavor.
Indications :
- CHF Stage C/D due to DCM or chronic valvular disease.
- Asymptomatic MVD (Stage B2) pre-CHF prevention.
- Canine hypertension with cardiac remodeling.
- Adjunct therapy with diuretics/ACE inhibitors.
Features :
- Improves ejection fraction and exercise capacity.
- Delays CHF onset and extends survival.
- Reduces cardiac remodeling and regurgitation.
- Easy compliance with flavored chewables.
Directions for Use:
-
Dosage: 0.25-0.3 mg/kg pimobendan BID (e.g., 1 tab for 8-10kg dog).
-
Administer orally 1 hour before feeding, every 12 hours.
-
Requires veterinary prescription; echocardiogram monitoring.
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
Description
This low-strength variant provides synergistic inodilator therapy pimobendan enhances cardiac contractility and vasodilation while benazepril (ACE inhibitor) reduces preload/afterload—for early-stage or small-breed canine heart disease management.
-
Composition : Pimobendan 2.5mg (positive inotrope/vasodilator).
Benazepril HCl 5mg (angiotensin-converting enzyme inhibitor).
Palatable chewable base with beef/liver flavor.
Indications :
- CHF Stage C/D due to DCM or chronic valvular disease.
- Asymptomatic MVD (Stage B2) pre-CHF prevention.
- Canine hypertension with cardiac remodeling.
- Adjunct therapy with diuretics/ACE inhibitors.
Features :
- Improves ejection fraction and exercise capacity.
- Delays CHF onset and extends survival.
- Reduces cardiac remodeling and regurgitation.
- Easy compliance with flavored chewables.
Directions for Use:
-
Dosage: 0.25-0.3 mg/kg pimobendan BID (e.g., 1 tab for 8-10kg dog).
-
Administer orally 1 hour before feeding, every 12 hours.
-
Requires veterinary prescription; echocardiogram monitoring.
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
